{"id":774880,"date":"2023-08-03T01:48:11","date_gmt":"2023-08-03T05:48:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/"},"modified":"2023-08-03T01:48:11","modified_gmt":"2023-08-03T05:48:11","slug":"clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/","title":{"rendered":"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ALPHARETTA, Ga., Aug.  02, 2023  (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS<sup>\u00ae<\/sup>), announced that management will participate in the following investor conferences in August 2023:<\/p>\n<p align=\"justify\">Chardan Virtual Ophthalmology Summit<br \/>Age-Related Macular Degeneration and Diabetes-Related Eye Diseases Series<br \/>Fireside Chat (Available on Demand)<\/p>\n<p align=\"justify\">BTIG Virtual Biotechnology Conference<br \/>Corporate Presentation and One-on-One Investor Meetings<br \/>August 7, 2023 at 2:30 pm (Presentation)<\/p>\n<p align=\"justify\">H.C. Wainwright 3<sup>rd<\/sup> Annual Ophthalmology Virtual Conference<br \/>Panel Discussion, Corporate Presentation and One-on-One Investor Meetings<br \/>August 16, 2023 at 11:00 am ET (Panel)<\/p>\n<p align=\"justify\">A link to available live and archived webcasts may be accessed on the Clearside website under the Investors section: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GP4uFo2Xv2RC5fGmV36aY0Cg7cvy9V-mrlRvw-VP83c3pkK262kwsbUNDnVjEDshNvyT6xo6_wJm1_-3A7bWq7TXF5xoYnWyiFoNVwGjFO03-eoT_P9IOzG2_YoCGNFNy8lgN9F6LAjYvbJ9DVr7Ug==\" rel=\"nofollow noopener\" target=\"_blank\">Events and Presentations<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Clearside Biomedical, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS<sup>\u00ae<\/sup>). Clearside\u2019s SCS injection platform, utilizing the Company\u2019s patented SCS Microinjector<sup>\u00ae<\/sup>, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company\u2019s lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD), is in Phase 2b clinical testing. Clearside developed and gained approval for its first product, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xqAYZRH9uPXhixwnleTwZB5HWEpbfmu3G8maiSHcHR9btBlpQmao_OJrLbLQZGAtgdPfolHISKHvhFbd7b9L6tTpBtXgkqPuOc70OSVRRYpUILphxI6hB-VVf7Bq4IrptCnwPdNqH56PXFI9Qn3bPg3YeByq_FTUQEs4nb7_BGM=\" rel=\"nofollow noopener\" target=\"_blank\">XIPERE\u00ae (triamcinolone acetonide injectable suspension)<\/a> for suprachoroidal use, which is available in the U.S. through a commercial partner. Clearside also strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m7YlsNjPmgjZZIXU3x2j8MljzTfcdx5eHL06S_jpOrhMI5NcwWsKJSFaLqpxgCLUAjp_wbvmvE7m9gW2hhZA41gUjCPcs-S8OZM1w58bW7k=\" rel=\"nofollow noopener\" target=\"_blank\">clearsidebio.com<\/a>.<\/p>\n<p>Source: Clearside Biomedical, Inc.<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MDZmNGRmZDItMTBhMC00MmRkLWI1ZjQtNDQyYTM2MmNiMzk5LTEwMjI3MzU=\/tiny\/Clearside-Biomedical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor and Media Contacts:\r\n\r\nJenny Kobin\r\nRemy Bernarda\r\nir@clearsidebio.com\r\n(678) 430-8206<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALPHARETTA, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae), announced that management will participate in the following investor conferences in August 2023: Chardan Virtual Ophthalmology SummitAge-Related Macular Degeneration and Diabetes-Related Eye Diseases SeriesFireside Chat (Available on Demand) BTIG Virtual Biotechnology ConferenceCorporate Presentation and One-on-One Investor MeetingsAugust 7, 2023 at 2:30 pm (Presentation) H.C. Wainwright 3rd Annual Ophthalmology Virtual ConferencePanel Discussion, Corporate Presentation and One-on-One Investor MeetingsAugust 16, 2023 at 11:00 am ET (Panel) A link to available live and archived webcasts may be accessed on the Clearside website under the Investors section: Events and Presentations. About Clearside Biomedical, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-774880","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALPHARETTA, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae), announced that management will participate in the following investor conferences in August 2023: Chardan Virtual Ophthalmology SummitAge-Related Macular Degeneration and Diabetes-Related Eye Diseases SeriesFireside Chat (Available on Demand) BTIG Virtual Biotechnology ConferenceCorporate Presentation and One-on-One Investor MeetingsAugust 7, 2023 at 2:30 pm (Presentation) H.C. Wainwright 3rd Annual Ophthalmology Virtual ConferencePanel Discussion, Corporate Presentation and One-on-One Investor MeetingsAugust 16, 2023 at 11:00 am ET (Panel) A link to available live and archived webcasts may be accessed on the Clearside website under the Investors section: Events and Presentations. About Clearside Biomedical, &hellip; Continue reading &quot;Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T05:48:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023\",\"datePublished\":\"2023-08-03T05:48:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/\",\"name\":\"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=\",\"datePublished\":\"2023-08-03T05:48:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/","og_locale":"en_US","og_type":"article","og_title":"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023 - Market Newsdesk","og_description":"ALPHARETTA, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae), announced that management will participate in the following investor conferences in August 2023: Chardan Virtual Ophthalmology SummitAge-Related Macular Degeneration and Diabetes-Related Eye Diseases SeriesFireside Chat (Available on Demand) BTIG Virtual Biotechnology ConferenceCorporate Presentation and One-on-One Investor MeetingsAugust 7, 2023 at 2:30 pm (Presentation) H.C. Wainwright 3rd Annual Ophthalmology Virtual ConferencePanel Discussion, Corporate Presentation and One-on-One Investor MeetingsAugust 16, 2023 at 11:00 am ET (Panel) A link to available live and archived webcasts may be accessed on the Clearside website under the Investors section: Events and Presentations. About Clearside Biomedical, &hellip; Continue reading \"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-03T05:48:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023","datePublished":"2023-08-03T05:48:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/"},"wordCount":291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/","name":"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=","datePublished":"2023-08-03T05:48:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjI0MiM1NzM0NTEwIzIwMTExNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-upcoming-investor-conferences-in-august-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=774880"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774880\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=774880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=774880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=774880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}